Inventor · disambiguated record
Ian Tarpey
Also filed as: TARPEY IAN
23 granted patents·9 pending applications·91 citations·filing 1998–2025
95Inventor score
Top patents by PatentIndex Score
32 records- 0195US10106607B2Caninized antibodiesINTERVET INC·Filed 2014·Granted Oct 23, 2018·22 cites·14 claims
- 0292US9944704B2Antibodies against canine PD-1INTERVET INC·Filed 2014·Granted Apr 17, 2018·8 cites·5 claims
- 0391US11680097B2Antibodies against canine PD-1INTERVET INC·Filed 2020·Granted Jun 20, 2023·2 cites·10 claims
- 0491US11229698B2Recombinant non-pathogenic Marek's Disease virus constructs encoding multiple heterologous antigensINTERVET INC·Filed 2018·Granted Jan 25, 2022·5 cites·20 claims
- 0589US10023636B2Caninized murine antibodies to human PD-1INTERVET INC·Filed 2014·Granted Jul 17, 2018·5 cites·4 claims
- 0688US11248047B2Caninized antibodiesINTERVET INC·Filed 2018·Granted Feb 15, 2022·2 cites·16 claims
- 0788US11229699B2Feline calicivirus vaccineINTERVET INC·Filed 2018·Granted Jan 25, 2022·2 cites·20 claims
- 0887US11311616B2Feline leukemia virus vaccineINTERVET INC·Filed 2018·Granted Apr 26, 2022·2 cites·20 claims
- 0987US10927172B2Caninized murine antibodies to human PD-1INTERVET INC·Filed 2018·Granted Feb 23, 2021·2 cites·10 claims
- 1087US10711061B2Antibodies against canine PD-1INTERVET INC·Filed 2018·Granted Jul 14, 2020·2 cites·17 claims
- 1186US11167027B2Multivalent feline vaccineINTERVET INC·Filed 2018·Granted Nov 9, 2021·2 cites·20 claims
- 1285US11447561B2PD-L1 antibodies binding canine PD-L1INTERVET INC·Filed 2019·Granted Sep 20, 2022·2 cites·12 claims
- 1385US2024084004A1Antibodies against canine pd-1INTERVET INC·Filed 2023·Application pending·0 cites
- 1484US9827305B2Poultry virus vaccines that are liquid stableINTERVET INC·Filed 2015·Granted Nov 28, 2017·5 cites·23 claims
- 1583US2024398934A1Feline leukemia virus vaccineINTERVET INC·Filed 2024·Application pending·0 cites
- 1681US12252536B2Caninized antibodiesINTERVET INC·Filed 2022·Granted Mar 18, 2025·0 cites·13 claims
- 1780US11596687B2Recombinant non-pathogenic Marek's disease virus constructs encoding infectious laryngotracheitis virus and infectious bursal disease virus antigensINTERVET INC·Filed 2017·Granted Mar 7, 2023·3 cites·25 claims
- 1880US2025277034A1Caninized AntibodiesINTERVET INC·Filed 2025·Application pending·0 cites
- 1978US12076392B2Feline leukemia virus vaccineINTERVET INC·Filed 2022·Granted Sep 3, 2024·0 cites·13 claims
- 2078US10550194B2PD-L1 antibodies binding canine PD-L1INTERVET INC·Filed 2015·Granted Feb 4, 2020·2 cites·12 claims
- 2174US11730809B2Multivalent feline vaccineINTERVET INC·Filed 2021·Granted Aug 22, 2023·0 cites·20 claims
- 2273US2022389114A1Pd-l1 antibodies binding canine pd-l1INTERVET INC·Filed 2022·Application pending·0 cites
- 2372US12239704B2Recombinant non-pathogenic Marek's disease virus constructs encoding multiple heterologous antigensINTERVET INC·Filed 2021·Granted Mar 4, 2025·0 cites·12 claims
- 2467US2024269259A1Rabies virus vaccineINTERVET INC·Filed 2024·Application pending·0 cites
- 2564US7445785B2Infectious bronchitis virus with an altered spike geneINTERVET INT BV·Filed 2004·Granted Nov 4, 2008·1 cites·10 claims
- 2660US11992526B2Rabies virus vaccineINTERVET INC·Filed 2018·Granted May 28, 2024·0 cites·18 claims
- 2757US6187759B1Canine parvovirus DNA vaccinationAKZO NOBEL NV·Filed 1998·Granted Feb 13, 2001·24 cites·17 claims
- 2854US2019008950A1Poultry virus vaccines that are liquid stableINTERVET INC·Filed 2018·Application pending·0 cites
- 2952US12435143B2Caninized antibodies against canine CTLA-4INTERVET INC·Filed 2020·Granted Oct 7, 2025·0 cites·20 claims
- 3052US2023355741A1Feline Severe Acute Respiratory Syndrome Coronavirus 2 VaccineINTERVET INC·Filed 2021·Application pending·0 cites
- 3151US2018104328A1Poultry virus vaccines that are liquid stableINTERVET INC·Filed 2017·Application pending·0 cites
- 3247US2023012140A1Oral respiratory vaccineINTERVET INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ian Tarpey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →